Digital clinical trials to accelerate the evaluation of colchicine therapy

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19
  • Known Financial Commitments (USD)

    $88,275
  • Funder

    IVADO
  • Principal Investigator

    Unspecified Jean-Claude and Frédéric Tardif and Lesage
  • Research Location

    Canada
  • Lead Research Institution

    N/A
  • Research Priority Alignment

    N/A
  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Prophylactic use of treatments

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Unspecified

  • Broad Policy Alignment

    Pending

  • Age Group

    Adults (18 and older)

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

This project, which has already received approval from Health Canada, the Québec Ministry of Health and Social Services and the Montréal Heart Institute's Ethics Committee, seeks to evaluate a colchicine-based treatment, including its impact on mortality rates and pulmonary complications. The scope of the task (recruitment of a cohort of 6,000 subjects) and the extremely tight deadline (as quickly as possible) for this type of project require the implementation of new digital recruitment and follow-up tools.